Page 6,403«..1020..6,4026,4036,4046,405..6,4106,420..»

Northeast Regional Epilepsy Group offers all-day Epilepsy Conference for Parents and Healthcare Providers on …

Posted: Published on October 10th, 2012

Epilepsy specialists will share their most updated knowledge on how to treat epilepsy and seizures through diets, epilepsy surgery, and anti-epileptic medications. Infantile spasms, Tuberous Sclerosis Complex, Lennox Gastaut Syndrome, Dravets Syndrome, genetics in epilepsy, autism, and how to deal with epilepsy emergencies will also be covered. Hackensack, NJ (PRWEB) October 10, 2012 This event is part of the 2012 Epilepsy: Knowledge is Powerful Campaign NEREG is holding throughout New York, New Jersey and Connecticut to promote Epilepsy Awareness. Dr. Marcelo Lancman, Medical Director of the Northeast Regional Epilepsy Group and a board certified epileptologist, commented: This year we launched a very ambitious educational program called Epilepsy: Knowledge is Power that aimed to raise epilepsy and seizure awareness thoughout the tri-state area. All in all, we have held 14 epilepsy conferences this year and have reached hundreds of patients, parents, loved ones, educators, and health professionals. With almost 3 million people in the U.S. having some form of epilepsy, and one in ten adults likely to experience a seizure during their life, it is completely necessary that more people are well informed about epilepsy facts and first aid. The November 16 program is meant for parents and health professionals alike. … Continue reading

Comments Off on Northeast Regional Epilepsy Group offers all-day Epilepsy Conference for Parents and Healthcare Providers on …

Utah parents pin autism treatment hopes on lottery

Posted: Published on October 10th, 2012

(Scott Sommerdorf | The Salt Lake Tribune) Damien Cook has autism. He loves to play with water and feel the tactile sensation of the water on his hands as he is doing here with his cat "Hissy" in his backyard in Tremonton, Monday, October 1, 2012. His mother, Loreena Cook, is among over 260 parents who have applied for limited spots in a new state-sponsored treatment program. Loreena Cook filled out Utahs application for free autism treatment a week ago, pinning her hopes for her 3-year-old sons future on a prayer. "Its not a good feeling," she said. "I feel almost like if Damien doesnt get it, there will be 250 other children who get help, and well just fall further behind." Its not too late Children between the ages of 2 and 6 who meet certain requirements can still apply for free, in-home autism treatment through the Utah Autism Waiver program. The state will take online and faxed applications until 11:59 p.m. on Oct. 31. Mail-in applications must be postmarked by Oct. 31. For more information go to http://www.health.utah.gov/autismwaiver. To be eligible, kids must: Be clinically diagnosed with an autism spectrum disorder. Be a U.S. citizen and Utah resident. … Continue reading

Comments Off on Utah parents pin autism treatment hopes on lottery

Stroke leads to lesser sentence for Miami Shores kidnapper

Posted: Published on October 10th, 2012

Four months before he kidnapped a Miami Shores Walgreens manager, held him at gunpoint as a human shield and got shot by cops, Adler Dupuy suffered a debilitating stroke. For that reason, a Miami-Dade judge on Wednesday gave Dupuy a significantly lowered sentence: 15 years in prison even though he faced a minimum of nearly 37. Saying the case offered a unique set of facts, Circuit Judge Yvonne Colodny said the stroke left lesions on the brain that had affected Dupuys ability to control his impulses and appreciate the consequences of his crime spree. On March 29, 2008, Dupuy sporting a black ski mask and wielding a handgun hid in the Walgreens, 9020 Biscayne Blvd., and surprised a group of employees around 6 a.m. Dupuy took a bag of cash and coins from them, but was still in the store when police arrived. In a dramatic scene caught on video by a news crew, the armed robber took the store manager hostage, shoved him through the parking lot and inside the mans Honda Civic. But the manager broke free, escaped the car and officers shot Dupuy as he drove off, crashing into a fence. Dupuy was later captured and hospitalized. … Continue reading

Comments Off on Stroke leads to lesser sentence for Miami Shores kidnapper

Concerns at stroke patients being taken to wrong hospital

Posted: Published on October 10th, 2012

Concerns at stroke patients being taken to wrong hospital 8:00am Wednesday 10th October 2012 in News By Barry Nelson, Health Editor DESPITE figures that show a new centralised stroke unit is improving treatment, councillors have voiced concerns that some patients are still not being taken to the right hospital. Since the Darlington Memorial acute stroke unit closed in December last year, suspected stroke patients in County Durham and Darlington are meant to be taken to a stroke unit at the University Hospital of North Durham, in Durham City. Since the unit opened in January, patients have been treated more quickly. Eighty-nine per cent of the 530 confirmed stroke patients treated between January and July this year were admitted directly to the North Durham unit. However, councillors from Darlington Borough Council are concerned that some suspected stroke patients are still being taken to Darlington Memorial Hospital. Councillor Tony Richmond, a member of the councils health and partnership scrutiny committee, which met yesterday, said: We have heard horror stories of patients being dumped in Darlington, but why is that? The logic behind all of this is that we can only afford to have a centre of excellence in one place. We are … Continue reading

Comments Off on Concerns at stroke patients being taken to wrong hospital

Fairview Improves Stroke Care with Toshiba’s Aquilion ONE Whole Brain Perfusion Protocol

Posted: Published on October 10th, 2012

TUSTIN, Calif.--(BUSINESS WIRE)-- To enhance its emergency department and stroke care capabilities, Fairview Health Services installed the AquilionTM ONE dynamic volume CT system from Toshiba America Medical Systems, Inc. at its Fairview Southdale Hospital in Edina, Minn. Fairview uses the Aquilion ONE with Toshibas advanced dose reduction technology, AIDR 3D, to perform whole brain perfusion and dynamic CT angiography and conduct general exams with less radiation dose in the emergency department. We selected Toshibas Aquilion ONE to perform safer whole brain perfusion imaging with significantly less radiation dose, said Alexander Zubkov, M.D., Ph.D., FAHA, director, Stroke Center, Fairview Health Services. The ability to view real-time brain function and dynamic blood flow is critical in acute stroke care. Aquilion ONE helps identify small clots or assess the overall impact of a stroke in the brain quickly to determine the optimal treatment pathway. Toshibas Aquilion ONE is the only CT system that covers up to 16 cm of anatomy with the thinnest 0.5 mm detector elements (640 unique slices) available. This reduces exam time, as well as radiation and contrast dose, and provides more accurate diagnoses. A new feature to the Aquilion ONE, Tech Assist Lateral Slide, enables clinicians and technologists to … Continue reading

Comments Off on Fairview Improves Stroke Care with Toshiba’s Aquilion ONE Whole Brain Perfusion Protocol

Neuralstem To Present Preclinical Data At Neuroscience 2012, 42nd Annual Meeting Of The Society For Neuroscience

Posted: Published on October 10th, 2012

ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) announced that it will present preclinical data in five poster presentations at Neuroscience 2012, the 42nd Annual Meeting for the Society for Neuroscience., October 13-17, in New Orleans (http://www.sfn.org/AM2012/). These posters will cover new data pertaining to Neuralstem's NSI-566 spinal cord stem cell line for cell therapy, and its patented, neurogenic small molecule compounds: NSI-144, NSI-150, NSI-158 and NSI-189. Abstracts of the poster are available at http://www.sfn.org/am2012/index.aspx?pagename=final_program (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) NSI-566 is in a Phase I trial to test the safety of the cells and procedure in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The last patient was treated in August, 2012. Neuralstem was recently approved to commence a NSI-566 trial in stroke in China, through its Chinese subsidiary, Neuralstem China, and has submitted an IND to the FDA to commence a trial in spinal cord injury with the same cells in the U.S. NSI-144, NSI-150, NSI-158 and NSI-189 are small molecule, orally active compounds that stimulate new neuron growth in the hippocampus. NSI-189 is currently in a Phase Ib clinical trial testing its safety for the treatment of major depressive disorder (MDD). The titles … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Neuralstem To Present Preclinical Data At Neuroscience 2012, 42nd Annual Meeting Of The Society For Neuroscience

Lawsuit accuses agency of negligence

Posted: Published on October 10th, 2012

UCP worker intentionally burned adult with hot water October 10, 2012 12:00 AM STOCKTON - The mother of a mentally disabled man has filed a lawsuit against United Cerebral Palsy after one of the organization's caretakers burned her son with scalding water. Court documents say former employee Matthew Telena placed the victim in a blistering shower after the client had soiled himself. Telena pleaded guilty to felony charges in criminal court and is serving a one-year sentence in the San Joaquin County Jail for the abuse. The victim's mother, Deanne Padilla, is suing the organization, claiming negligence and dependent adult abuse. Telena additionally is being sued for negligence, battery and assault. "It appears this guy was unfit to be around and taking care of these disabled individuals," said Padilla's attorney Ray Waters of the Stockton law firm Drivon, Turner & Waters. "It's a horrible way to treat people who are in that position." Padilla said prior to the burning incident, she had called the organization multiple times to complain that Telena was not caring for her son properly, and she suspected he caused an injury to her son's nose, her lawsuit says. She said they didn't take action to protect … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Lawsuit accuses agency of negligence

Amarantus BioSciences Provides Update to Shareholders

Posted: Published on October 10th, 2012

SUNNYVALE, Calif., Oct. 10, 2012 /PRNewswire/ --Amarantus BioSciences, Inc. (AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today provided the following update to shareholders from its President & CEO Gerald E. Commissiong: "The fundamental progress the Company has made since our First Annual CEO Letter was released in May has been quite significant. We have achieved the following milestones: While these developments are of significant importance for the Company, advancing MANF as a disease-modifying treatment for Parkinson's disease continues to be our primary focus. We anticipate announcing interim results from on-going delivery experiments by the end of October. The Company is working to secure funding to advance MANF towards an Investigational New Drug filing for Parkinson's disease with the Food and Drug Administration. As new and exciting proof-of-concept data for MANF in secondary therapeutic indications continues to be published by research laboratories throughout Europe, China, Japan and North America, the value of our intellectual property ("IP") portfolio is steadily increasing. We are continually expanding our IP portfolio for MANF by filing and aggregating new patents. As we further carve-out our position as the partner … Continue reading

Posted in Brain Injury Treatment | Comments Off on Amarantus BioSciences Provides Update to Shareholders

Braintree Rehabilitation Hospital To Sponsor 33rd Annual Neurorehabilitation Conference November 3 – 4

Posted: Published on October 10th, 2012

BRAINTREE, Mass., Oct. 10, 2012 /PRNewswire/ -- Braintree Rehabilitation Hospital (BRH), a world- class rehabilitative care provider, will sponsor the 33rd Annual Neurorehabilitation Conference Saturday and Sunday, November 3 and 4, at the Hyatt Regency Hotel in Cambridge, Massachusetts. One of the longest running and most prestigious conferences of its kind, this event brings together thought-leaders in traumatic brain injury, stroke and other neurologic disorders to present the most recent research and clinical findings and discuss their impact on patient treatment. "Neuroplasticity - the brain's ability to remodel itself following injury - is an extraordinary capacity of the brain," said Dr. Douglas Katz, Medical Director of the nationally recognized Acquired Brain Injury Program at BRH. "By better understanding this mechanism, we can leverage its power to enhance recovery and improve quality of life for patients." The conference will feature a veritable Who's Who of specialists in neurology, stroke, spinal cord injury, neurotechnology and more. The conference's featured presenter will be Randolph Nudo, M.D., Director, Langdon Center on Aging; Marian Merrell Dow Distinguished Professor in Aging; and Professor, Department of Molecular and Integrative Physiology, University of Kansas Medical Center. His topic will be "Harnessing the Potential of Neuroplasticity to Improve Recovery … Continue reading

Posted in Brain Injury Treatment | Comments Off on Braintree Rehabilitation Hospital To Sponsor 33rd Annual Neurorehabilitation Conference November 3 – 4

Scots scientist in MS breakthrough

Posted: Published on October 10th, 2012

Dr Iain Comerford, originally from Glasgow, who is working with MS Research Australia on a fellowship at the University of Adelaide, has managed to stop progression of the disease in mice using a new drug. The drug blocks the activity of a molecule known as PI3Kgamma, which is involved in the activation and movement of white blood cells, and protects against the damage to the nervous system associated with MS. Blocking the molecule reduces the release of inflammation-inducing molecules from immune cells and also dramatically decreases the movement of immune cells into the central nervous system. The research has already discovered new ways to treat human inflammatory disorders, such as diabetes and rheumatoid arthritis, and has now been extended to MS. Dr Comerford, a former Glasgow University student who also trained at the Beatson Institute, said human trials of the drug are already under way in other labs around the world. However, he said it would be at least another five years before any treatment is made available to humans. He said: "It will now be crucial to determine whether targeting these molecules could be a safe and effective way to treat MS in humans. "In the animal model, it … Continue reading

Posted in MS Treatment | Comments Off on Scots scientist in MS breakthrough

Page 6,403«..1020..6,4026,4036,4046,405..6,4106,420..»